Quick Order Cart

Cat. No. ARG27519

GTPBP1 Knockout HAP1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone Marrow

  • Disease:

    Chronic myeloid leukemia

The GTPBP1 Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from HAP1 human near-haploid cells. This model disrupts GTPBP1, a translational GTPase critical for ribosome recycling and stress granule dynamics. GTPBP1 interacts with ABCE1 and eRF3/GSPT1 and functions downstream of mTORC1, regulating translation under cellular stress. Ideal for investigating translation control, stress granule dynamics, and associated diseases such as cancer and microcephaly. Experimental approaches include Western blotting, puromycin incorporation, stress granule imaging, polysome profiling, and co-immunoprecipitation with interacting partners like ABCE1 and eRF3.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HAP1

    Sex of Donor

    Male

    Age

    40 years

    Derived From Site

    Bone marrow

    Gene Name

    GTPBP1

    Gene Identifier

    NCBI Gene ID 9567

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    IMDM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The GTPBP1 Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population in which the GTPBP1 gene is disrupted, generating a loss-of-function model. This product consists of a heterogeneous pool of HAP1 cells with targeted gene disruptions, enabling functional studies without clonal isolation. The polyclonal format provides a reproducible system for investigating GTPBP1’s roles in translation elongation, ribosome recycling, and stress granule dynamics.

The HAP1 cell line is a human near-haploid fibroblast-like line originally derived from the KBM-7 chronic myelogenous leukemia (CML) line. Its near-haploid karyotype, with a single copy of most chromosomes, simplifies genetic manipulation and phenotypic analysis, as gene disruptions often yield unambiguous loss-of-function phenotypes. HAP1 cells are widely employed in CRISPR-based functional genomics screens and detailed mechanistic studies, offering a physiologically relevant model for human disease research.

GTPBP1 encodes a conserved translational GTPase that facilitates ribosome recycling during both elongation and termination phases of protein synthesis. The protein operates downstream of mTORC1 signaling and is activated by cellular stresses such as oxidative stress and heat shock. GTPBP1 directly interacts with ABCE1 and the eukaryotic peptide release factor eRF3 (also known as GSPT1) to drive ribosome dissociation. Additionally, it associates with poly(A)-binding protein PABPC1 and localizes to stress granules by interacting with core markers G3BP1 and TIA1. Through these interactions, GTPBP1 modulates stress granule assembly and disassembly, thereby coordinating translational repression with stress adaptation and autophagy pathways.

In the near-haploid HAP1 background, disruption of GTPBP1 eliminates functional redundancy, making it an ideal system to dissect the protein’s role in translation control and stress responses. Researchers can utilize this polyclonal population to probe how loss of GTPBP1 affects ribosome recycling kinetics, translation fidelity, and the dynamics of stress granule formation and clearance. Such studies are directly relevant to understanding translational dysregulation in cancer, where tumor cells rely on stress adaptation, and in neurodevelopmental disorders like microcephaly, which have been linked to defects in ribosome function and protein synthesis.

The GTPBP1 Knockout HAP1 Polyclonal Cells are suitable for a broad spectrum of experimental approaches. Applications include dissecting translation regulation mechanisms, characterizing stress granule biology, modeling cancer-related translational control, and investigating neurodevelopmental pathologies. Compatible assays encompass Western blotting for protein expression analysis, puromycin incorporation to measure global translation rates, immunofluorescence microscopy to visualize stress granule markers (G3BP1, TIA1), polysome profiling and ribosome profiling for translation status, co-immunoprecipitation to confirm protein interactions (e.g., with ABCE1 and eRF3), and flow cytometry for quantification of translation activity. For detailed technical support and ordering, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)